Paperpal Prime Logo

Journal of Thrombosis and Haemostasis : Impact Factor & More

eISSN: 1538-7836pISSN: 1538-7933

Aims and Scope of Journal of Thrombosis and Haemostasis

The Journal of Thrombosis and Haemostasis is a monthly peer-reviewed medical journal covering research on thrombosis and hematology in general. It is published by Wiley-Blackwell and the editors-in-chief are David Lillicrap and James Morrissey. Former editors-in-chief include Frits Rosendaal, Pieter Reitsma, Mike Greaves, David Lane, Pier Mannucci, Jos Vermylen, Jan Sixma, Francois Duckert, and Rosemary Biggs. It is an official journal of the International Society on Thrombosis and Haemostasis. Less

Key Metrics

CiteScore
17.9
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
Scite Index
0.88 5-Year SI
SJR
Q1Hematology
SNIP
3.04
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Thrombosis and Haemostasis

Journal of Thrombosis and Haemostasis Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER SCIENCE INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Thrombosis and Haemostasis ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Thrombosis and Haemostasis

Pharmacology of anticoagulants: from heparin to novel target-specific agents.
  • 7 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
Prevalence and thrombotic risk of PF4-dependent platelet-activating antibodies.
  • 7 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia.
  • 3 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
Traumatic disseminated intravascular coagulation: a narrative review of modern concepts in pathophysiology, diagnosis, and management.
  • 1 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
A light in the dark-reframing direct oral anticoagulant pharmacokinetics and pharmacodynamics for near-patient decision-making.
  • 1 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
Development of models for predicting the 7-month risk of venous thromboembolism and clinically relevant bleeding in ambulatory patients with cancer: analysis from the apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients trial.
  • 1 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
Pharmacology of anticoagulants: from heparin to novel target-specific agents.
  • 7 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
Prevalence and thrombotic risk of PF4-dependent platelet-activating antibodies.
  • 7 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia.
  • 3 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
Traumatic disseminated intravascular coagulation: a narrative review of modern concepts in pathophysiology, diagnosis, and management.
  • 1 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
A light in the dark-reframing direct oral anticoagulant pharmacokinetics and pharmacodynamics for near-patient decision-making.
  • 1 Aug 2026
  • Journal of thrombosis and haemostasis : JTH
Development of models for predicting the 7-month risk of venous thromboembolism and clinically relevant bleeding in ambulatory patients with cancer: analysis from the apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients trial.
  • 1 Aug 2026
  • Journal of thrombosis and haemostasis : JTH

FAQs on Journal of Thrombosis and Haemostasis